Join
Live feed
·
PRReleasevia Quantisnow
argenx SE logo
Forte Biosciences Inc. logo

argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

ByQuantisnow·Wall Street's wire, on your screen.
ARGX· argenx SEFBRX· Forte Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARGX (argenx SE), FBRX (Forte Biosciences Inc.) and more on Quantisnow.